Activated TKT further upregulated programmed death-ligand 1 (PD-L1) and VRK2 expression by decreasing reactive oxygen species (ROS) accumulation and mTOR activation, resulting in immune evasion and HCC metastasis [62]. The gene discussed is TKT; the disease is hepatocellular carcinoma.